UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

The New England journal of medicine, 2019-07, Vol.381 (4), p.338-348

2019

Volltextzugriff (PDF)

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-12, Vol.383 (24), p.2345-2357

2020

Volltextzugriff (PDF)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1015-1026

2017

Volltextzugriff (PDF)

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

The New England journal of medicine, 2018-04, Vol.378 (15), p.1408-1418

2018

Volltextzugriff (PDF)

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

The New England journal of medicine, 2023-02, Vol.388 (8), p.719-732

2023

Volltextzugriff (PDF)

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

The New England journal of medicine, 2024-03, Vol.390 (10), p.875-888

2024

Volltextzugriff (PDF)

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

The New England journal of medicine, 2014-07, Vol.371 (5), p.424-433

2014

Volltextzugriff (PDF)

Management of brain metastases from germ cell tumours

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16076-16076

2008

Volltextzugriff (PDF)

Small cell cancer of the bladder: The Léon-Bérard Cancer Center experience

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16147-16147

2008

Volltextzugriff (PDF)

Uncommon bladder tumours

Bulletin du cancer, 2010, Vol.97 Suppl Cancer de la vessie, p.51

2010

Volltextzugriff (PDF)

Management of side effects associated with antiangiogenic treatment in renal cell carcinoma

Bulletin du cancer, 2010, Vol.97, p.73

2010

Volltextzugriff (PDF)

A phase II multicenter evaluation of ARQ 197 monotherapy in patients with relapsed or refractory germ cell tumors (GCTs)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4638-4638

2011

Volltextzugriff (PDF)

2- 18 fluoro-deoxy-d-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residuals: A retrospective validation of the SEMPET trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4581-4581

2010

Volltextzugriff (PDF)

Conventional-dose versus high-dose chemotherapy in relapsed or refractory male germ-cell tumors: A retrospective study in 1,594 patients

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4513-4513

2010

Volltextzugriff (PDF)

Major prognostic value of modeled AUC hCG-AFP , a dynamic kinetic marker characterizing tumor marker decline of nonseminomatous germ cell tumors (NSGCT) intermediate-poor-risk patients according to the IGCCCG

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5085-5085

2009

Volltextzugriff (PDF)

Thoracic surgery of residual masses after first-line chemotherapy in patients with testicular (T) or primary retroperitoneal (PR) non seminomatous germ cell tumors (NSGCT)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14563-14563

2006

Volltextzugriff (PDF)

Results of a phase II study of carboplatin and etoposide in patients with progressive metastatic castration refractory prostate cancer (mCRPC) and neuro-endocrine differentiation

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16073-e16073

2009

Volltextzugriff (PDF)

Management of clinical stage (CS) I and II patients with non-seminomatous germ cell tumors of the testis (NSGCTT) avoiding upfront retroperitoneal lymph node dissection (RPLND)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5090-5090

2007

Volltextzugriff (PDF)

Docetaxel-based chemotherapy in elderly patients (≥ 75 years) with castration resistant prostate cancer (CRPC): A French National study of 175 patients

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5145-5145

2008

Volltextzugriff (PDF)

Retrospective study of locally advanced bladder cancer in elderly patients

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.18523-18523

2006

Volltextzugriff (PDF)

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

The New England journal of medicine, 2013-01, Vol.368 (2), p.138-148

2013

Volltextzugriff (PDF)

Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): impact on outcome

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4584-4584

2004

Volltextzugriff (PDF)

Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): impact on outcome

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4584-4584

2004

Volltextzugriff (PDF)

A phase II multicentre study of oxaliplatin (Ox) in combination with paclitaxel (Px) in patients (pts) who failed cisplatin (CDDP) based chemotherapy (CT) for germ cell tumors (GCT)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4534-4534

2004

Volltextzugriff (PDF)

A phase II multicentre study of oxaliplatin (Ox) in combination with paclitaxel (Px) in patients (pts) who failed cisplatin (CDDP) based chemotherapy (CT) for germ cell tumors (GCT)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4534-4534

2004

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Zeitschrift / SerieAnnals Of Oncology

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(128)

Sprache

Englisch
(119)
Französisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(27)
Male
(21)
Oncology
(18)
Animals
(13)
Female
(11)
Life Sciences
(11)
Chemotherapy
(10)
General & Internal Medicine
(10)
Medicine, General & Internal
(10)
Aged
(9)
Biological And Medical Sciences
(9)
Middle Aged
(9)
Antineoplastic Agents - Therapeutic Use
(8)
Metastases
(8)
Patients
(8)
Prostate Cancer
(8)
Survival
(8)
Aged, 80 And Over
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Management of brain metastases from germ cell tumours

Small cell cancer of the bladder: The Léon-Bérard Cancer Center experience

Uncommon bladder tumours

Management of side effects associated with antiangiogenic treatment in renal cell carcinoma

A phase II multicenter evaluation of ARQ 197 monotherapy in patients with relapsed or refractory germ cell tumors (GCTs)

2- 18 fluoro-deoxy-d-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residuals: A retrospective validation of the SEMPET trial

Conventional-dose versus high-dose chemotherapy in relapsed or refractory male germ-cell tumors: A retrospective study in 1,594 patients

Major prognostic value of modeled AUC hCG-AFP , a dynamic kinetic marker characterizing tumor marker decline of nonseminomatous germ cell tumors (NSGCT) intermediate-poor-risk patients according to the IGCCCG

Thoracic surgery of residual masses after first-line chemotherapy in patients with testicular (T) or primary retroperitoneal (PR) non seminomatous germ cell tumors (NSGCT)

Results of a phase II study of carboplatin and etoposide in patients with progressive metastatic castration refractory prostate cancer (mCRPC) and neuro-endocrine differentiation

Management of clinical stage (CS) I and II patients with non-seminomatous germ cell tumors of the testis (NSGCTT) avoiding upfront retroperitoneal lymph node dissection (RPLND)

Docetaxel-based chemotherapy in elderly patients (≥ 75 years) with castration resistant prostate cancer (CRPC): A French National study of 175 patients

Retrospective study of locally advanced bladder cancer in elderly patients

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): impact on outcome

Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): impact on outcome

A phase II multicentre study of oxaliplatin (Ox) in combination with paclitaxel (Px) in patients (pts) who failed cisplatin (CDDP) based chemotherapy (CT) for germ cell tumors (GCT)

A phase II multicentre study of oxaliplatin (Ox) in combination with paclitaxel (Px) in patients (pts) who failed cisplatin (CDDP) based chemotherapy (CT) for germ cell tumors (GCT)

Aktive Filter

Suchergebnisse filtern